AV
Avanos Medical, Inc.
AVNS · NYSE
$24.99 +0.04% (+$0.01)
Market Cap $1.17B
P/E Ratio -
Div. Yield -
ROE 8.55%
Bulios Fair Price
$18.68
25.3% downside
Current Price
$24.99
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AVNS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
68 /100
Cheap P/S 1.67x
P/B 1.50x
P/FCF 27.16x
Growth
12 /100
Declining Rev. growth 0.83%
FCF growth 15.57%
Book val. growth 15.53%
Profitability
34 /100
Moderate Gross margin 49.77%
Net margin 9.68%
Op. margin 8.78%
Quality
8 /100
Poor ROIC 6.82%
ROE 8.55%
ROA 6.32%
Debt
69 /100
Low Debt/Equity 0.17x
Current ratio 2.15x
Int. coverage -15.55x
Stability
38 /100
Moderate Beta 1.57x
Rev. volatility 2.10%
EPS volatility 312.13%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AVNS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
David C. Pacitti
Employees
2,287
Headquarters
Alpharetta